Niu, F.-W.; Zhang, Y.-J.; Li, K.; Zhang, M.-S. Nobiletin Acts As a Potential Anticancer Agent Against Osteosarcoma by Regulating ERK and AKT Signaling Pathways. Bangladesh J Pharmacol 2014, 9, 406-412.